Literature DB >> 6520261

Tissue-specific autoantibodies and autoimmune disorders in vitiligo and alopecia areata: a retrospective study.

W Korkij, K Soltani, S Simjee, P G Marcincin, T Y Chuang.   

Abstract

We retrospectively analyzed our laboratory reports of tissue-specific autoantibodies (TSA) in 38 patients with alopecia areata (AA) and 31 patients with vitiligo. These reports were based on standard indirect immunofluorescence (IF) procedures, employing monkey tissues as substrates. One or more TSA were detected in 39% of serum samples. Thyroid (microsomal and/or thyroglobulin) antibodies had the highest occurrence rate and, as compared with the normal population, were detected at a greater frequency in both vitiligo and AA. Over half (58%) of our patients with vitiligo had one or more detectable TSA, while only 28% of patients with AA had such antibodies. When compared with the normal population, the occurrence rate of TSA was higher in patients with vitiligo. The only remarkable finding in AA was a higher than normal occurrence rate of antithyroid antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520261     DOI: 10.1111/j.1600-0560.1984.tb00413.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Alopecia totalis and vitiligo in common variable immunodeficiency.

Authors:  G Spickett; A G Prentice; T Wallington; A D Webster; H Chapel
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 2.  Immunology of alopecia areata.

Authors:  Marta Żeberkiewicz; Lidia Rudnicka; Jacek Malejczyk
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

3.  Anti-thyroid peroxidase antibody and vitiligo: a controlled study.

Authors:  Maryam Daneshpazhooh; Mahtab Mostofizadeh G; Javad Behjati; Maryam Akhyani; Reza Mahmoud Robati
Journal:  BMC Dermatol       Date:  2006-03-10

4.  Thyroid disorders associated with alopecia areata in egyptian patients.

Authors:  Ola A Bakry; Mohamed A Basha; Maather K El Shafiee; Wafaa A Shehata
Journal:  Indian J Dermatol       Date:  2014-01       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.